change the use of anticoagulant therapy for venous thromboembolism (VTE)

October 2008

New Chest guidelines will change the use of anticoagulant therapy for venous thromboembolism (VTE).

Initial treatment. Prescribe low-molecular-weight heparins (LMWH) as the standard initial treatment for most patients.

But consider SC unfractionated heparin, IV unfractionated heparin, or fondaparinux (Arixtra) as alternatives.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote